当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第30期
编号:13102107
肺癌全基因组关联研究进展(5)
http://www.100md.com 2017年10月25日 《中国医药导报》 2017年第30期
     [27] Hu L,Wu C,Zhao X,et al. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy [J]. Clinic Cancer Res,2012,18(19):5507-5514.

    [28] Wu C,Xu B,Yuan P,et al. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients [J]. Cancer Res,2010,70(23):9721-9729.

    [29] Shi J,Chatterjee N,Rotunno M,et al. Inherited variation at chromosome 12p13.33 including RAD52 influences squamous cell lung carcinoma risk [J]. Cancer Discov,2012,2(2):131-139.

    [30] Spitz MR,Gorlov IP,Amos CI,et al. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke [J]. Cancer Discov,2011,1(5):420-429.

    [31] Feng Y,Wang Y,Liu H,et al. Genetic variants of PTPN2 are associated with lung cancer risk:A re-analysis of eight GWASs in the TRICL-ILCCO consortium [J]. Sci Rep,2017,7(1):130-144.

    (收稿日期:2017-07-07 本文編辑:程 铭), http://www.100md.com(杨兴礼 付永全 刘小军 张玮 陶涛)
上一页1 2 3 4 5